Changes in the Occurrence, Severity, and Distress of Symptoms in Patients With Gastrointestinal Cancers Receiving Chemotherapy

Ilufredo Y. Tantoy, Bruce A. Cooper, Anand Dhruva, Janine Cataldo, Steven M. Paul, Yvette P. Conley, Marilyn Hammer, Fay Wright, Laura B. Dunn, Jon D. Levine, Christine Miaskowski

Research output: Contribution to journalArticle

Abstract

Context: Studies on multiple dimensions of the symptom experience of patients with gastrointestinal cancers are extremely limited. Objective: Purpose was to evaluate for changes over time in the occurrence, severity, and distress of seven common symptoms in these patients. Methods: Patients completed Memorial Symptom Assessment Scale, six times over two cycles of chemotherapy (CTX). Changes over time in occurrence, severity, and distress of pain, lack of energy, nausea, feeling drowsy, difficulty sleeping, and change in the way food tastes were evaluated using multilevel regression analyses. In the conditional models, effects of treatment group (i.e., with or without targeted therapy), age, number of metastatic sites, time from cancer diagnosis, number of prior cancer treatments, cancer diagnosis, and CTX regimen on enrollment levels, as well as the trajectories of symptom occurrence, severity, and distress were evaluated. Results: Although the occurrence rates for pain, lack of energy, feeling drowsy, difficulty sleeping, and change in the way food tastes declined over the two cycles of CTX, nausea and numbness/tingling in hands/feet had more complex patterns of occurrence. Severity and distress ratings for the seven symptoms varied across the two cycles of CTX. Conclusions: Demographic and clinical characteristics associated with differences in enrollment levels as well as changes over time in occurrence, severity, and distress of these seven common symptoms were highly variable. These findings can be used to identify patients who are at higher risk for more severe and distressing symptoms during CTX and to enable the initiation of preemptive symptom management interventions.

Original languageEnglish (US)
JournalJournal of Pain and Symptom Management
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Gastrointestinal Neoplasms
Drug Therapy
Nausea
Emotions
Multilevel Analysis
Pain
Food
Neoplasms
Symptom Assessment
Hypesthesia
Foot
Therapeutics
Hand
Regression Analysis
Demography

Keywords

  • Chemotherapy
  • Distress
  • Fatigue
  • Feeling drowsy
  • Gastrointestinal cancer
  • Pain
  • Severity
  • Sleep disturbance
  • Targeted therapy
  • Taste changes

ASJC Scopus subject areas

  • Nursing(all)
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Changes in the Occurrence, Severity, and Distress of Symptoms in Patients With Gastrointestinal Cancers Receiving Chemotherapy. / Tantoy, Ilufredo Y.; Cooper, Bruce A.; Dhruva, Anand; Cataldo, Janine; Paul, Steven M.; Conley, Yvette P.; Hammer, Marilyn; Wright, Fay; Dunn, Laura B.; Levine, Jon D.; Miaskowski, Christine.

In: Journal of Pain and Symptom Management, 01.01.2018.

Research output: Contribution to journalArticle

Tantoy, Ilufredo Y. ; Cooper, Bruce A. ; Dhruva, Anand ; Cataldo, Janine ; Paul, Steven M. ; Conley, Yvette P. ; Hammer, Marilyn ; Wright, Fay ; Dunn, Laura B. ; Levine, Jon D. ; Miaskowski, Christine. / Changes in the Occurrence, Severity, and Distress of Symptoms in Patients With Gastrointestinal Cancers Receiving Chemotherapy. In: Journal of Pain and Symptom Management. 2018.
@article{c2853ee6db514c758976e7a4971a5ff5,
title = "Changes in the Occurrence, Severity, and Distress of Symptoms in Patients With Gastrointestinal Cancers Receiving Chemotherapy",
abstract = "Context: Studies on multiple dimensions of the symptom experience of patients with gastrointestinal cancers are extremely limited. Objective: Purpose was to evaluate for changes over time in the occurrence, severity, and distress of seven common symptoms in these patients. Methods: Patients completed Memorial Symptom Assessment Scale, six times over two cycles of chemotherapy (CTX). Changes over time in occurrence, severity, and distress of pain, lack of energy, nausea, feeling drowsy, difficulty sleeping, and change in the way food tastes were evaluated using multilevel regression analyses. In the conditional models, effects of treatment group (i.e., with or without targeted therapy), age, number of metastatic sites, time from cancer diagnosis, number of prior cancer treatments, cancer diagnosis, and CTX regimen on enrollment levels, as well as the trajectories of symptom occurrence, severity, and distress were evaluated. Results: Although the occurrence rates for pain, lack of energy, feeling drowsy, difficulty sleeping, and change in the way food tastes declined over the two cycles of CTX, nausea and numbness/tingling in hands/feet had more complex patterns of occurrence. Severity and distress ratings for the seven symptoms varied across the two cycles of CTX. Conclusions: Demographic and clinical characteristics associated with differences in enrollment levels as well as changes over time in occurrence, severity, and distress of these seven common symptoms were highly variable. These findings can be used to identify patients who are at higher risk for more severe and distressing symptoms during CTX and to enable the initiation of preemptive symptom management interventions.",
keywords = "Chemotherapy, Distress, Fatigue, Feeling drowsy, Gastrointestinal cancer, Pain, Severity, Sleep disturbance, Targeted therapy, Taste changes",
author = "Tantoy, {Ilufredo Y.} and Cooper, {Bruce A.} and Anand Dhruva and Janine Cataldo and Paul, {Steven M.} and Conley, {Yvette P.} and Marilyn Hammer and Fay Wright and Dunn, {Laura B.} and Levine, {Jon D.} and Christine Miaskowski",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jpainsymman.2017.10.004",
language = "English (US)",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Changes in the Occurrence, Severity, and Distress of Symptoms in Patients With Gastrointestinal Cancers Receiving Chemotherapy

AU - Tantoy, Ilufredo Y.

AU - Cooper, Bruce A.

AU - Dhruva, Anand

AU - Cataldo, Janine

AU - Paul, Steven M.

AU - Conley, Yvette P.

AU - Hammer, Marilyn

AU - Wright, Fay

AU - Dunn, Laura B.

AU - Levine, Jon D.

AU - Miaskowski, Christine

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Context: Studies on multiple dimensions of the symptom experience of patients with gastrointestinal cancers are extremely limited. Objective: Purpose was to evaluate for changes over time in the occurrence, severity, and distress of seven common symptoms in these patients. Methods: Patients completed Memorial Symptom Assessment Scale, six times over two cycles of chemotherapy (CTX). Changes over time in occurrence, severity, and distress of pain, lack of energy, nausea, feeling drowsy, difficulty sleeping, and change in the way food tastes were evaluated using multilevel regression analyses. In the conditional models, effects of treatment group (i.e., with or without targeted therapy), age, number of metastatic sites, time from cancer diagnosis, number of prior cancer treatments, cancer diagnosis, and CTX regimen on enrollment levels, as well as the trajectories of symptom occurrence, severity, and distress were evaluated. Results: Although the occurrence rates for pain, lack of energy, feeling drowsy, difficulty sleeping, and change in the way food tastes declined over the two cycles of CTX, nausea and numbness/tingling in hands/feet had more complex patterns of occurrence. Severity and distress ratings for the seven symptoms varied across the two cycles of CTX. Conclusions: Demographic and clinical characteristics associated with differences in enrollment levels as well as changes over time in occurrence, severity, and distress of these seven common symptoms were highly variable. These findings can be used to identify patients who are at higher risk for more severe and distressing symptoms during CTX and to enable the initiation of preemptive symptom management interventions.

AB - Context: Studies on multiple dimensions of the symptom experience of patients with gastrointestinal cancers are extremely limited. Objective: Purpose was to evaluate for changes over time in the occurrence, severity, and distress of seven common symptoms in these patients. Methods: Patients completed Memorial Symptom Assessment Scale, six times over two cycles of chemotherapy (CTX). Changes over time in occurrence, severity, and distress of pain, lack of energy, nausea, feeling drowsy, difficulty sleeping, and change in the way food tastes were evaluated using multilevel regression analyses. In the conditional models, effects of treatment group (i.e., with or without targeted therapy), age, number of metastatic sites, time from cancer diagnosis, number of prior cancer treatments, cancer diagnosis, and CTX regimen on enrollment levels, as well as the trajectories of symptom occurrence, severity, and distress were evaluated. Results: Although the occurrence rates for pain, lack of energy, feeling drowsy, difficulty sleeping, and change in the way food tastes declined over the two cycles of CTX, nausea and numbness/tingling in hands/feet had more complex patterns of occurrence. Severity and distress ratings for the seven symptoms varied across the two cycles of CTX. Conclusions: Demographic and clinical characteristics associated with differences in enrollment levels as well as changes over time in occurrence, severity, and distress of these seven common symptoms were highly variable. These findings can be used to identify patients who are at higher risk for more severe and distressing symptoms during CTX and to enable the initiation of preemptive symptom management interventions.

KW - Chemotherapy

KW - Distress

KW - Fatigue

KW - Feeling drowsy

KW - Gastrointestinal cancer

KW - Pain

KW - Severity

KW - Sleep disturbance

KW - Targeted therapy

KW - Taste changes

UR - http://www.scopus.com/inward/record.url?scp=85039969440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039969440&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2017.10.004

DO - 10.1016/j.jpainsymman.2017.10.004

M3 - Article

C2 - 29051114

AN - SCOPUS:85039969440

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

ER -